Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Neurogene (NGNE)  
$3.68 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 41,890,000
Market Cap: 154.16(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $3.68 - $3.68
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Neoleukin Therapeutics is a biopharmaceutical company creating immunotherapies for cancer, inflammation, and autoimmunity using de novo protein design technology. Co. is initially focused on key cytokine mimetics, which it refers to as Neoleukin de novo cytokine mimetics. Co.'s primary product candidate, NL-201, is a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin-2, or IL-2, and interleukin-15, or IL-15, for the potential treatment of various types of cancer, including renal cell carcinoma, melanoma, and hematological malignancies, while limiting the toxicity caused by the preferential binding of native IL-2 and IL-15 to non-target cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 120,270 2,405,612
Total Buy Value $0 $0 $2,720,023 $4,183,510
Total People Bought 0 0 3 4
Total Buy Transactions 0 0 3 6
Total Shares Sold 6,797 11,298 11,298 12,621
Total Sell Value $103,003 $179,250 $179,250 $180,068
Total People Sold 1 2 2 3
Total Sell Transactions 1 2 2 3
End Date 2025-03-16 2024-12-13 2024-06-14 2023-06-15

   
Records found: 119
  Page 1 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Cobb Stuart Chief Scientific Officer   •       –      –    2025-05-14 4 AS $15.15 $103,003 D/D (6,797) 20,794     -
   Cvijic Christine Mikail President and CFO   •       –      –    2025-03-26 4 A $0.00 $0 D/D 20,300 92,643     -
   Jordan Julie Chief Medical Officer   •       –      –    2025-03-26 4 A $0.00 $0 D/D 8,400 8,400     -
   Cobb Stuart Chief Scientific Officer   •       –      –    2025-03-26 4 A $0.00 $0 D/D 7,200 27,591     -
   Mcminn Rachel Chief Executive Officer   •       •      –    2025-03-26 4 A $0.00 $0 D/D 23,900 1,274,259     -
   Cvijic Christine Mikail President and CFO   •       –      –    2025-03-13 4 S $16.94 $76,247 D/D (4,501) 72,343     -
   Akkaraju Srinivas 10% Owner   –       –       •   2024-11-26 4 B $24.91 $1,259,623 I/I 48,770 1,717,127 1.5     -
   Akkaraju Srinivas 10% Owner   –       –       •   2024-11-25 3 IO $0.00 $0 I/I 0 1,668,357     -
   Mcminn Rachel Chief Executive Officer   •       •      –    2024-11-22 4 B $20.40 $969,000 D/D 47,500 1,297,859 2.81     -
   Cvijic Christine Mikail President and CFO   •       –      –    2024-11-22 4 B $20.48 $491,400 D/D 24,000 76,844 2.74     -
   Cobb Stuart Chief Scientific Officer   •       –      –    2024-03-13 4 A $0.00 $0 D/D 20,391 20,391     -
   Cvijic Christine Mikail President and CFO   •       –      –    2024-03-13 4 A $0.00 $0 D/D 31,903 52,844     -
   Cvijic Christine Mikail President and CFO   •       –      –    2023-12-18 3 IO $0.00 $0 D/D 0 20,941     -
   Mcminn Rachel Chief Executive Officer   •       •      –    2023-12-18 3 IO $0.00 $0 D/D 0 1,250,359     -
   Baker Bros. Advisors (gp) Llc Director   –       •       •   2023-10-05 4 OE $0.00 $0 I/I 592,650 1,658,190     -
   Baker Bros. Advisors (gp) Llc Director   –       •       •   2023-08-17 4 B $0.69 $115,617 I/I 166,942 5,612,949 2.25     -
   Baker Bros. Advisors (gp) Llc Director   –       •       •   2023-08-16 4 B $0.68 $156,254 I/I 229,600 5,458,724 2.25     -
   Baker Bros. Advisors (gp) Llc Director   –       •       •   2023-08-15 4 B $0.63 $1,191,616 I/I 1,888,800 5,246,614 2.25     -
   Smith Sean Michael Interim CFO, Prin Acct Off   •       –      –    2023-08-11 4 S $0.62 $818 D/D (1,323) 21,637     -
   Smith Sean Michael Interim CFO, Prin Acct Off   •       –      –    2023-08-10 4 OE $0.00 $0 D/D 5,000 22,960     -
   Patel Priti Chief Medical Officer   •       –      –    2023-02-02 4 S $0.60 $8,588 D/D (14,380) 31,082     -
   Smith Sean Michael Principal Accounting Officer   •       –      –    2023-02-02 4 S $0.60 $1,980 D/D (3,316) 15,960     -
   Patel Priti Chief Medical Officer   •       –      –    2023-02-01 4 OE $0.00 $0 D/D 35,000 45,462     -
   Smith Sean Michael Principal Accounting Officer   •       –      –    2023-02-01 4 OE $0.00 $0 D/D 12,500 19,276     -
   Smith Sean Michael Principal Accounting Officer   •       –      –    2022-08-10 4 S $0.99 $1,641 D/D (1,655) 6,776     -
  119 Records found
  1  2  3  4  5   
  Page 1 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us